Ovagen Fertility makes reproductive technology products that support fertility treatment for individuals and couples.
Founded by Terence D. and headquartered in Los Angeles, US, Ovagen Fertility works on reproductive technologies that aim to improve fertility treatment outcomes. Its solutions are sold to healthcare providers through annual subscriptions and direct sales. In June 2015 MTS Health Partners invested, with terms undisclosed, and the company has completed one deal. Plans include launching new products by mid-2023 and establishing a presence in Germany and Japan by 2024.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in